Nothing Special   »   [go: up one dir, main page]

Vargaftig et al., 1980 - Google Patents

Platelet-activating factor induces a platelet-dependent bronchoconstriction unrelated to the formation of prostaglandin derivatives

Vargaftig et al., 1980

Document ID
4355620754533111837
Author
Vargaftig B
Lefort J
Chignard M
Benveniste J
Publication year
Publication venue
European journal of pharmacology

External Links

Snippet

Platelet-activating factor (PAF-acether) is a phospholipid derivative released from stimulated basophils, macrophages and platelets. It induced the release of ATP from, and aggregated guinea-pig platelets. These effects were inhibited by neither aspirin nor eicosatetraynoic …
Continue reading at www.sciencedirect.com (other versions)

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic, hydroximic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/8215—Micro-organisms

Similar Documents

Publication Publication Date Title
Vargaftig et al. Platelet-activating factor induces a platelet-dependent bronchoconstriction unrelated to the formation of prostaglandin derivatives
Whittle et al. Comparison of the effects of prostacyclin (PGI2), prostaglandin E1 and D2 on platelet aggregation in different species
Alhenc-Gelas et al. Stimulation of prostaglandin formation by vasoactive mediators in cultured human endothelial cells
Corvazier et al. Interference of some flavonoids and non-steroidal anti-inflammatory drugs with oxidative metabolism of arachidonic acid by human platelets and neutrophils
Goud et al. Assembled and unassembled pools of clathrin: a quantitative study using an enzyme immunoassay.
Gresele et al. Serum albumin enhances the impairment of platelet aggregation with thromboxane synthase inhibition by increasing the formation of prostaglandin D2
Barnes et al. Platelet-activating factor as a mediator of allergic disease
Suggs et al. Prostacyclin expression by a continuous human cell line derived from vascular endothelium
Namm et al. Species specificity of the platelet responses to 1-0-alkyl-2-acetyl-sn-glycero-3-phosphocholine
Trevisani et al. Elevated levels of prostaglandin E2 in Yoshida hepatoma and the inhibition of tumour growth by non-steroidal anti-inflammatory drugs
Cesbron et al. Platelets mediate the action of diethylcarbamazine on microfilariae
Gordon Jr et al. Role of serum albumin in lipemia clearing reaction
Creese et al. Sources of calcium for contraction of guinea‐pig isolated tracheal smooth muscle
Blackham et al. The role of prostaglandins in rabbit monoarticular arthritis
EP0630245B1 (en) Protein kinase c inhibitor
Carlini et al. Platelet release reaction and aggregation induced by canatoxin, a convulsant protein: evidence for the involvement of the platelet lipoxygenase pathway.
Bult et al. Blood levels of 6-oxo-prostaglandin F1α during endotoxin-induced hypotension in rabbits
Katyare et al. Heterogeneity of rat liver mitochondrial fractions and the effect of tri-iodothyronine on their protein turnover
Giembycz et al. Platelet activating factor stimulates cyclo-oxygenase activity in guinea pig eosinophils. Concerted biosynthesis of thromboxane A2 and E-series prostaglandins.
Buchanan et al. The sex-related differences in aspirin pharmacokinetics in rabbits and man and its relationship to antiplatelet effects
Ritchie et al. SRSA-mediated bronchospasm by pharmacologic modification of lung anaphylaxis in vivo
Jouvin-Marche et al. Effect of the Ca2+ antagonist nifedipine on the release of platelet-activating factor (PAF-acether), slow-reacting substance and β-glucuronidase from human neutrophils
Chung et al. PAF antagonists: their potential therapeutic role in asthma
Sautebin et al. Release of leukotrienes, induced by the Ca++ ionophore A23187, from human lung parenchyma in vitro.
DE69431167T2 (en) METHOD FOR SELECTIVE METHIONINE DRAWNING FOR MALIGNE MAMMAL CELLS